SOPHiA Genetics SA
$5.01
17
+$0.13+2.66% Tuesday 20:00
Statistics
Day High
5.09
Day Low
4.86
52W High
5.52
52W Low
2.85
Volume
58,233
Avg. Volume
-
Mkt Cap
338.58M
P/E Ratio
-
Dividend Yield
-
Dividend
-
Upcoming
Earnings
11AugExpected
Expected EPS
-0.225
Actual EPS
N/A
Financials
-95.89%Profit Margin
Unprofitable130.35MRevenue
-124.99MNet Income
Analyst Ratings
7.5Average Price Target
The highest estimate is 8.00.
From 2 ratings within the last 6 months. This is not an investment recommendation.
From 2 ratings within the last 6 months. This is not an investment recommendation.
Buy 100%
Hold 0%
Sell 0%
People Also Follow
This list is based on the watchlists of people on Stock Events who follow SOPH. It's not an investment recommendation.
Competitors
This list is an analysis based on recent market events. It's not an investment recommendation.
Illumina
ILMN
Mkt Cap21.85B
Pacific Biosciences of California
PACB
Mkt Cap378.93M
Guardant Health
GH
Mkt Cap15.77B
Fulgent Genetics
FLGT
Mkt Cap485.93M
Qiagen NV
QGEN
Mkt Cap7.25B
Bionano Genomics
BNGO
Mkt Cap14.23M
Thermo Fisher Scientific
TMO
Mkt Cap166.59B
Intellia Therapeutics
NTLA
Mkt Cap1.76B
About
SOPHiA GENETICS SA operates as a cloud-native software technology company in the healthcare space. It offers SOPHiA DDM platform, a cloud-native software platform for analyzing data and generating insights from multimodal data sets and diagnostic modalities. Its SOPHiA DDM platform and related solutions, applications, products, and services are used by hospitals, laboratories, and biopharmaceutical companies through its own sales force as well as distributors and industry collaborators in Switzerland, France, Italy, rest of Europe, North America, the United States, Latin America, and the Asia-pacific. The company has a partnership with Synnovis to bring blood-based cancer testing to patients in the United Kingdom. The company was incorporated in 2011 and is based in Rolle, Switzerland.
Show more...
CEO
Dr. Jurgi Camblong M.B.A., Ph.D.
Employees
423
Country
Switzerland
ISIN
CH1125843347
Listings
0 Comments
Share your thoughts
FAQ
What is SOPHiA Genetics SA stock price today?▼
The current price of SOPH is $5.01 USD — it has increased by +2.66% in the past 24 hours. Watch SOPHiA Genetics SA stock price performance more closely on the chart.
What is SOPHiA Genetics SA stock ticker?▼
Depending on the exchange, the stock ticker may vary. For instance, on exchange SOPHiA Genetics SA stocks are traded under the ticker SOPH.
Is SOPHiA Genetics SA stock price growing?▼
SOPH stock has risen by +2.87% compared to the previous week, the month change is a +3.09% rise, over the last year SOPHiA Genetics SA has showed a +72.76% increase.
What is SOPHiA Genetics SA market cap?▼
Today SOPHiA Genetics SA has the market capitalization of 338.58M
When is the next SOPHiA Genetics SA earnings date?▼
SOPHiA Genetics SA is going to release the next earnings report on August 11, 2026.
What were SOPHiA Genetics SA earnings last quarter?▼
SOPH earnings for the last quarter are -0.27 USD per share, whereas the estimation was -0.23 USD resulting in a -16.13% surprise. The estimated earnings for the next quarter are N/A USD per share.
What is SOPHiA Genetics SA revenue for the last year?▼
SOPHiA Genetics SA revenue for the last year amounts to 130.35M USD.
What is SOPHiA Genetics SA net income for the last year?▼
SOPH net income for the last year is -124.99M USD.
How many employees does SOPHiA Genetics SA have?▼
As of May 27, 2026, the company has 423 employees.
In which sector is SOPHiA Genetics SA located?▼
SOPHiA Genetics SA operates in the Health & Wellness sector.
When did SOPHiA Genetics SA complete a stock split?▼
SOPHiA Genetics SA has not had any recent stock splits.
Where is SOPHiA Genetics SA headquartered?▼
SOPHiA Genetics SA is headquartered in Rolle, Switzerland.